Zevra Therapeutics (ZVRA) Share-based Compensation (2014 - 2026)
Zevra Therapeutics (ZVRA) posted Share-based Compensation of $2.67 million for Q3 2026, down 3.6% from $2.77 million a year earlier and down 10.0% from the prior quarter.
Powered by 
Analysis
Zevra Therapeutics (ZVRA) Share-based Compensation (2014 - 2026) Analysis & Trends
For the trailing twelve months through Sep 30, 2026, Share-based Compensation at Zevra Therapeutics was $13.03 million, up 5.4% year-over-year; for FY2025, it came in at $12.63 million, down 15.2% from FY2024.
- Annual Share-based Compensation shows a five-year compound annual growth rate of 38.4% (FY2020 to FY2025).
- In prior years, Zevra Therapeutics' Share-based Compensation was $14.91 million in FY2024 (+150.4%), $5.95 million in FY2023 (+38.7%), $4.29 million in FY2022 (+76.3%) and $2.44 million in FY2021 (-2.2%).
- The Q3 2026 figure stands as the lowest quarterly Share-based Compensation since Q2 2025.
- On a year-over-year basis, Share-based Compensation increased in four of the last eight quarters, with growth averaging 22.7%.
- The strongest year-over-year quarter for Share-based Compensation in the past five years was Q2 2022, with growth of 374.8%; the weakest was Q3 2025, with a decline of 54.8%.
- According to Business Quant data, Share-based Compensation for the three prior quarters was $2.97 million (Q2 2026), $3.11 million (Q1 2026) and $4.28 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 200.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 357.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 160.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 369.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 128.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 234.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 362.00 Mn |
| 10 | Zevra Therapeutics | 708.52 Mn | -100.24 Mn | 36.01 Mn | 2.67 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 2.67 Mn |
| Jun 30, 2026 | 2.97 Mn |
| Mar 31, 2026 | 3.11 Mn |
| Dec 31, 2025 | 4.28 Mn |
| Sep 30, 2025 | 2.77 Mn |
| Jun 30, 2025 | 2.46 Mn |
| Mar 31, 2025 | 3.12 Mn |
| Dec 31, 2024 | 4.02 Mn |
| Sep 30, 2024 | 6.14 Mn |
| Jun 30, 2024 | 2.63 Mn |
| Mar 31, 2024 | 2.12 Mn |
| Dec 31, 2023 | 1.47 Mn |
| Sep 30, 2023 | 1.39 Mn |
| Jun 30, 2023 | 1.10 Mn |
| Mar 31, 2023 | 945,000.00 |
| Dec 31, 2022 | 955,000.00 |
| Sep 30, 2022 | 911,000.00 |
| Jun 30, 2022 | 1.51 Mn |
| Mar 31, 2022 | 918,000.00 |
| Dec 31, 2021 | 823,000.00 |
API Access
Zevra Therapeutics Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ZVRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "ZVRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ZVRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();